[go: up one dir, main page]

HUE064916T2 - Gyógyászati készítmény - Google Patents

Gyógyászati készítmény

Info

Publication number
HUE064916T2
HUE064916T2 HUE20700453A HUE20700453A HUE064916T2 HU E064916 T2 HUE064916 T2 HU E064916T2 HU E20700453 A HUE20700453 A HU E20700453A HU E20700453 A HUE20700453 A HU E20700453A HU E064916 T2 HUE064916 T2 HU E064916T2
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
HUE20700453A
Other languages
English (en)
Inventor
Christophe Roberge
Noriega Adolfo Lopez
Jean Manuel Cros
Juliette Serindoux
Murielle Oster
Fang Liu
Charlotte Molinier
Sylvestre Grizot
Tjasa Vrlinic
Feifei Ng
Elise Guegain
Marie-Emerentienne Cagnon
Original Assignee
Medincell S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medincell S A filed Critical Medincell S A
Publication of HUE064916T2 publication Critical patent/HUE064916T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HUE20700453A 2019-01-08 2020-01-08 Gyógyászati készítmény HUE064916T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1900258.3A GB201900258D0 (en) 2019-01-08 2019-01-08 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
HUE064916T2 true HUE064916T2 (hu) 2024-04-28

Family

ID=65528088

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE20700453A HUE064916T2 (hu) 2019-01-08 2020-01-08 Gyógyászati készítmény

Country Status (25)

Country Link
US (2) US20220118003A1 (hu)
EP (2) EP3908321B1 (hu)
JP (1) JP2022517939A (hu)
KR (1) KR20210113251A (hu)
CN (1) CN113543775B (hu)
AU (1) AU2020205438B8 (hu)
BR (1) BR112021013456A2 (hu)
CA (1) CA3125372A1 (hu)
DK (1) DK3908321T3 (hu)
EA (1) EA202191603A1 (hu)
ES (1) ES2968432T3 (hu)
FI (1) FI3908321T3 (hu)
GB (1) GB201900258D0 (hu)
HR (1) HRP20231667T1 (hu)
HU (1) HUE064916T2 (hu)
LT (1) LT3908321T (hu)
MX (1) MX2021008248A (hu)
PH (1) PH12021551642A1 (hu)
PL (1) PL3908321T3 (hu)
PT (1) PT3908321T (hu)
RS (1) RS65067B1 (hu)
SI (1) SI3908321T1 (hu)
SM (1) SMT202400011T1 (hu)
WO (1) WO2020144239A1 (hu)
ZA (1) ZA202104704B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118159252A (zh) 2021-08-05 2024-06-07 美蒂森股份公司 药物组合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2016A (en) 1841-03-26 Mode of constructing fireplaces and chimney-staoks ii
FR2741628B1 (fr) 1995-11-29 1998-02-06 Centre Nat Rech Scient Nouveaux hydrogels a base de copolymeres trisequences et leur application notamment a la liberation progressive de principes actifs
US6461631B1 (en) 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
KR100416242B1 (ko) * 1999-12-22 2004-01-31 주식회사 삼양사 약물전달체용 생분해성 블록 공중합체의 액체 조성물 및이의 제조방법
US7649023B2 (en) * 2002-06-11 2010-01-19 Novartis Ag Biodegradable block copolymeric compositions for drug delivery
WO2008066787A2 (en) * 2006-11-27 2008-06-05 E. I. Du Pont De Nemours And Company Multi-functional polyalkylene oxides, hydrogels and tissue adhesives
WO2010053918A1 (en) * 2008-11-05 2010-05-14 Hancock Jaffe Laboratories, Inc. Composite containing collagen and elastin as a dermal expander and tissue filler
EP3257498B1 (en) 2010-12-29 2019-04-24 Medincell Biodegradable drug delivery compositions
CN102432852B (zh) * 2011-08-25 2013-10-16 复旦大学 一种聚乳酸基立构复合交联共聚物及其制备方法
IN2014DN11063A (hu) * 2012-06-27 2015-09-25 Medincell
EP2983716A4 (en) 2013-04-11 2017-01-25 Commonwealth Scientific and Industrial Research Organisation Composition for controlled delivery of bioactive agents
CN114886899B (zh) * 2014-04-21 2024-02-13 赫伦治疗有限公司 长效聚合物输送系统
PT3377041T (pt) * 2015-11-16 2023-12-15 Maria Pereira Da Cruz Alves Garcia Método para morcelação e/ou direcionamento de princípios farmaceuticamente ativos ao tecido sinovial
HRP20250087T1 (hr) 2017-07-17 2025-03-28 Medincell S.A. Farmaceutski pripravak
CN108586775B (zh) * 2018-05-04 2019-11-12 四川大学 可用于眼内长期填充的原位交联超支化聚醚类水凝胶及其制备方法

Also Published As

Publication number Publication date
HRP20231667T1 (hr) 2024-03-15
PH12021551642A1 (en) 2022-05-23
CN113543775A (zh) 2021-10-22
EP4289429A3 (en) 2024-03-20
AU2020205438B2 (en) 2025-02-06
EP3908321B1 (en) 2023-11-15
AU2020205438B9 (en) 2025-03-27
AU2020205438B8 (en) 2025-03-27
AU2020205438A1 (en) 2021-07-29
EP4289429A2 (en) 2023-12-13
EA202191603A1 (ru) 2021-10-20
PT3908321T (pt) 2024-01-15
LT3908321T (lt) 2024-01-25
RS65067B1 (sr) 2024-02-29
US20220118003A1 (en) 2022-04-21
KR20210113251A (ko) 2021-09-15
EP3908321A1 (en) 2021-11-17
US20240293444A1 (en) 2024-09-05
PL3908321T3 (pl) 2024-03-25
WO2020144239A1 (en) 2020-07-16
JP2022517939A (ja) 2022-03-11
MX2021008248A (es) 2021-10-13
SI3908321T1 (sl) 2024-03-29
ES2968432T3 (es) 2024-05-09
CN113543775B (zh) 2023-11-24
CA3125372A1 (en) 2020-07-16
ZA202104704B (en) 2024-11-27
FI3908321T3 (fi) 2024-01-11
GB201900258D0 (en) 2019-02-27
DK3908321T3 (da) 2024-01-15
BR112021013456A2 (pt) 2021-09-14
SMT202400011T1 (it) 2024-03-13

Similar Documents

Publication Publication Date Title
GB201911928D0 (en) Pharmaceutical compounds
GB201911517D0 (en) Pharmaceutical composition
GB202008961D0 (en) Pharmaceutical composition
IL276888A (en) Pharmaceutical compositions containing timolol
GB201911944D0 (en) Pharmaceutical compounds
GB201804548D0 (en) Pharmaceutical compositions
IL290469A (en) Oral pharmaceutical preparation
GB201914910D0 (en) Pharmaceutical compounds
GB201807053D0 (en) Pharmaceutical composition
IL291570A (en) Pharmaceutical preparations
GB201808571D0 (en) Pharmaceutical compositions
SG11202103374TA (en) Pharmaceutical composition
GB201915932D0 (en) Pharmaceutical compounds
GB201915273D0 (en) Pharmaceutical compounds
GB201901989D0 (en) Pharmaceutical combinations
GB201808567D0 (en) Pharmaceutical compositions
IL285728A (en) Pharmaceutical composition
SG11202110315SA (en) Pharmaceutical composition
HUE064916T2 (hu) Gyógyászati készítmény
GB201912686D0 (en) Pharmaceutical composition
GB201908003D0 (en) Pharmaceutical composition
ZA202006541B (en) Pharmaceutical composition comprising brexpiprazole
GB201820689D0 (en) Pharmaceutical composition
GB201904783D0 (en) New pharmaceutical compositions
GB201904771D0 (en) New pharmaceutical compositions